Evidence map›Paper›PMID 27980681›Full record

ArticleEpigenetics & chromatin2016

Targeted bisulfite sequencing of the dynamic DNA methylome.

Michael J Ziller, Elena K Stamenova, Hongcang Gu, Andreas Gnirke, Alexander Meissner

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.Journal of molecular and cellular cardiology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Michael J ZillerMax Planck Institute of Psychiatry, 80804 Munich, Germany.
Elena K StamenovaBroad Institute of MIT and Harvard, Cambridge, MA 02142 USA.
Hongcang GuBroad Institute of MIT and Harvard, Cambridge, MA 02142 USA.
Andreas GnirkeBroad Institute of MIT and Harvard, Cambridge, MA 02142 USA.
Alexander MeissnerBroad Institute of MIT and Harvard, Cambridge, MA 02142 USA ; Harvard Stem Cell Institute, Cambridge, MA 02138 USA ; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138 USA ; Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.ORCID 0000-0001-8646-7469
Broad Institute · USMax Planck Institute of Psychiatry · DE

Funding

Epigenomic variation atlas across human tissues and individuals in GTExU01HG007610 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KELLIS, MANOLIS · 2014 to 2016
$3.0M
NHGRI NIH HHS U01 HG007610
6 · The paper itself

Abstract

backgroundThe ability to measure DNA methylation precisely and efficiently continues to drive our understanding of this modification in development and disease. Whole genome bisulfite sequencing has the advantage of theoretically capturing all cytosines in the genome at single-nucleotide resolution, but it has a number of significant practical drawbacks that become amplified with increasing sample numbers. All other technologies capture only a fraction of the cytosines that show dynamic regulation across cell and tissue types.

resultsHere, we present a novel hybrid selection design focusing on loci with dynamic methylation that captures a large number of differentially methylated gene-regulatory elements. We benchmarked this assay against matched whole genome data and profiled 25 human tissue samples to explore its ability to detect differentially methylated regions.

conclusionsOur target capture design fills a major gap left by all other assays that exist to map DNA methylation. It maintains the ability to link cytosine methylation to genetic differences, the single-base resolution and the analysis of neighboring cytosines while notably reducing the cost per sample by focusing the sequencing effort on the most informative and relevant regions of the genome.

Indexed as

DNA MethylationChromatin ImmunoprecipitationCpG IslandsDNAGenome, HumanHigh-Throughput Nucleotide SequencingHistonesHumansSequence Analysis, DNASulfitesDNAHistoneshydrogen sulfiteSulfitesBisulfite sequencingDNA methylationTarget enrichment

Identifiers

PMID27980681
PMCPMC5135789
OpenAlexW2557774362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.